Genetic CRC test yields mixed results

04/19/2013 | MedPage Today (free registration)

Data from Exact Sciences showed its DNA-based Cologuard test had 92% sensitivity for colorectal cancer, but only 42% sensitivity for finding precancerous polyps. The Agency for Healthcare Research and Quality last year found that there was insufficient evidence to support the use of tests such as Cologaurd in cancer screening.

View Full Article in:

MedPage Today (free registration)

Published in Brief: